Literature DB >> 26216377

Orexins and fear: implications for the treatment of anxiety disorders.

África Flores1, Rocío Saravia1, Rafael Maldonado2, Fernando Berrendero3.   

Abstract

An understanding of the neurobiological mechanisms involved in the regulation of fear is essential for the development of new treatments for anxiety disorders, such as phobias, panic, and post-traumatic stress disorders (PTSD). Orexins, also known as hypocretins, are neuropeptides located exclusively in hypothalamic neurons that have extensive projections throughout the central nervous system. Although this system was initially believed to be primarily involved in the regulation of feeding behavior, recent studies have shown that orexins also modulate neural circuits implicated in the expression and extinction of fear memories. Here, we discuss recent findings involving orexins in anxiety disorders and current clinical trials using orexin ligands that could be applied to identify new therapies for diseases characterized by pathological fear.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  amygdala; anxiety; fear; orexin; prefrontal cortex

Mesh:

Substances:

Year:  2015        PMID: 26216377     DOI: 10.1016/j.tins.2015.06.005

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  26 in total

Review 1.  Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour.

Authors:  Patricia Bonnavion; Laura E Mickelsen; Akie Fujita; Luis de Lecea; Alexander C Jackson
Journal:  J Physiol       Date:  2016-07-19       Impact factor: 5.182

2.  Activation of orexin/hypocretin neurons is associated with individual differences in cued fear extinction.

Authors:  Amanda C Sharko; Jim R Fadel; Kris F Kaigler; Marlene A Wilson
Journal:  Physiol Behav       Date:  2016-10-13

3.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

4.  Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure.

Authors:  Marlene A Wilson; Israel Liberzon; Merry L Lindsey; Yana Lokshina; Victoria B Risbrough; Renu Sah; Susan K Wood; John B Williamson; Francis G Spinale
Journal:  Stress       Date:  2019-06-04       Impact factor: 3.493

Review 5.  The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.

Authors:  David E Moorman
Journal:  Psychopharmacology (Berl)       Date:  2018-03-06       Impact factor: 4.530

6.  Overexpression of ORX or MCH Protects Neurological Function Against Ischemic Stroke.

Authors:  Gang Wu; Xi'an Zhang; Shijun Li; Dan Zhou; Jie Bai; Hanxiang Wang; Qing Shu
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

Review 7.  The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders.

Authors:  Gerard Sanacora; Zhen Yan; Maurizio Popoli
Journal:  Nat Rev Neurosci       Date:  2021-12-10       Impact factor: 34.870

Review 8.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

Review 9.  Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders.

Authors:  Ying Han; Kai Yuan; Yongbo Zheng; Lin Lu
Journal:  Neurosci Bull       Date:  2019-11-28       Impact factor: 5.203

10.  A comparison of the orexin receptor distribution in the brain between diurnal Nile grass rats (Arvicanthis niloticus) and nocturnal mice (Mus musculus).

Authors:  Tomoko Ikeno; Lily Yan
Journal:  Brain Res       Date:  2018-04-06       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.